Texas Judge Matthew J Kacsmaryk is reviewing the FDA’s decades-old approval of mifepristone in a case that could bear the most damaging ruling to reproductive rights since Dobbs.
It’s one of the most significant abortion cases in post-Roe America and the Trump-appointed judge overseeing it is trying to shroud the suit in secrecy. Texas judge an anti-LGBTQ+ extremist who has written in opposition to contraceptive care and reproductive rights hearing oral arguments Wednesday in an extraordinary lawsuit seeking to overturn the Food and Drug Administration’s two-decade approval of mifepristone, which is used in more than 50 percent of abortions in the US and has been become a mark among Republicans in the wake of the Supreme Court’s 2022 Dobbs decision.
The case, brought by the antiabortion Alliance for Hippocratic Medicine, could have broad implications for healthcare in America, including in states where abortion remains legal. But Kacsmaryk who was first nominated by Doland Trump in 2017 and eventually confirmed in 2019, has attempted to keep the proceedings from playing out under the public eye- a single, perhaps, that he intends to side with the hardline Christian group suing the FDA.
Matthew J Kacsmaryk Has Delayed Putting Wednesday’s Hearing
Citing supposed threats and saying he didn’t want protesters to create a circus-like atmosphere around the proceedings Matthew J Kacsmaryk has delayed putting Wednesday’s hearing. He thinks fewer advertisements of this hearing is better the judge said.
Nevertheless, the Washington Post and other outlets reported news of the major Wednesday hearing, and organizations planned demonstrations outside the Amarillo, Texas courthouse, where only a handful of press and public were allowed to view the proceedings.